← back to search

Evan W. Newell

Fred Hutch Cancer Center ·
Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, and Cancer Immunotherapy and Biomarkers.
h-index
78
citations
27,346
works
392
NIH funding
primary concept
Medicine
email

Recent publications

PD-1 is requisite for skin TRM cell formation and specification by TGFβ
Nature Immunology 2025cited by 18position: middledoi
Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature
Proceedings of the National Academy of Sciences 2025cited by 5position: middledoi
Epstein-Barr-virus-specific functional antibody signatures in the context of nasopharyngeal carcinoma development
Med 2025cited by 1position: middledoi
snPATHO-seq, a versatile FFPE single-nucleus RNA sequencing method to unlock pathology archives
Communications Biology 2024cited by 29position: middledoi
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols
Nature Cancer 2024cited by 29position: middledoi
Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya
EMBO Molecular Medicine 2024cited by 18position: middledoi
Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus
Cell Reports Medicine 2024cited by 10position: middledoi
94 CyTOF and serum proteomics show distinct differences in immune responses between mycosis fungoides and sezary syndrome to mono- and combination anti-PD-1 immunotherapy
Regular and Young Investigator Award Abstracts 2022cited by 0position: middledoi
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
Journal of Clinical Investigation 2021cited by 276position: middledoi
A subset of Kupffer cells regulates metabolism through the expression of CD36
Immunity 2021cited by 229position: middledoi
Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC
Journal of Thoracic Oncology 2021cited by 87position: middledoi
Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans
Nature Immunology 2020cited by 318position: middledoi
Combinatorial Single-Cell Analyses of Granulocyte-Monocyte Progenitor Heterogeneity Reveals an Early Uni-potent Neutrophil Progenitor
Immunity 2020cited by 264position: middledoi
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection
Gastroenterology 2020cited by 190position: middledoi
Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank
Neuro-Oncology 2020cited by 93position: middledoi
Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits
Nature Communications 2020cited by 79position: middledoi
Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer
Cell Reports Medicine 2020cited by 57position: lastdoi
Engineered niches support the development of human dendritic cells in humanized mice
Nature Communications 2020cited by 31position: middledoi
Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells
Immunity 2019cited by 505position: middledoi
Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects
The Journal of Infectious Diseases 2019cited by 118position: middledoi
Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer
Journal for ImmunoTherapy of Cancer 2019cited by 101position: middledoi
Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection
Science Immunology 2019cited by 83position: lastdoi
Lung endothelial cell antigen cross-presentation to CD8+T cells drives malaria-associated lung injury
Nature Communications 2019cited by 80position: middledoi
Large-Scale HLA Tetramer Tracking of T Cells during Dengue Infection Reveals Broad Acute Activation and Differentiation into Two Memory Cell Fates
Immunity 2019cited by 51position: lastdoi
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Nature 2018cited by 1,378position: lastdoi
Developmental Analysis of Bone Marrow Neutrophils Reveals Populations Specialized in Expansion, Trafficking, and Effector Functions
Immunity 2018cited by 703position: middledoi
PD-1 blockade partially recovers dysfunctional virus–specific B cells in chronic hepatitis B infection
Journal of Clinical Investigation 2018cited by 280position: middledoi
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
Cancer Research 2018cited by 143position: middledoi
Mapping of γ/δ T cells reveals Vδ2+ T cells resistance to senescence
EBioMedicine 2018cited by 77position: middledoi
Mapping the human DC lineage through the integration of high-dimensional techniques
Science 2017cited by 563position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark M. Davis · Case Western Reserve University12 papers (2012–2017)Jinmiao Chen · First Affiliated Hospital of Guangzhou Medical University7 papers (2015–2019)Étienne Becht · Seattle University5 papers (2019–2024)Antonio Bertoletti · Duke-NUS Medical School5 papers (2016–2020)Bernett Lee · Nanyang Technological University4 papers (2019–2020)Charles‐Antoine Dutertre · Inserm4 papers (2017–2020)Anis Larbi · National University of Singapore4 papers (2015–2020)Florent Ginhoux · Rockefeller University4 papers (2015–2020)Brian Kidd · Research Triangle Park Foundation4 papers (2012–2015)Natalia Sigal · Stanford University3 papers (2012–2013)Daniel S.W. Tan · National Cancer Centre Singapore3 papers (2016–2021)Laurent Rénia · Hospital Universitario de Gran Canaria Doctor Negrín3 papers (2015–2024) · 3 papers (2016–2019)Angela Takano · Singapore General Hospital3 papers (2016–2021)Stephen C. De Rosa · Fred Hutch Cancer Center3 papers (2014–2025)Yannick Simoni · Nanyang Technological University3 papers (2018–2021) · 3 papers (2015–2020)Laura Rivino · University of Bristol3 papers (2017–2020)Michael Poidinger · National University of Singapore3 papers (2015–2019)Upkar S. Gill · University College London2 papers (2018–2020)